ClinicalTrials.Veeva

Menu

Extending the hCG OPU Interval (DelOPU)

B

Baruch Padeh Medical Center

Status

Unknown

Conditions

Infertility

Treatments

Other: Delaying oocyte pick up beyond 39 hours post hCG

Study type

Interventional

Funder types

Other

Identifiers

NCT02871154
0041-16-POR

Details and patient eligibility

About

Our and others experience suggest that in some cases delaying oocyte pick up (OPU) for more than 39 hours after hCG injection may be of benefit.

We plan to apply this to 20 women in whom less than 20% of oocytes were found suitable for intracytoplasmic sperm injection. The delay will be for up to an interval of 47 hours from hCG to OPU.

Full description

In IVF one encounters some women in whom a low percentage of oocytes are found in the metaphase II stage upon their retrieval. Following some incidents, in our experience as well as others', where women injected hCG too early but oocytes were still retrieved with high proportion of maturity, we decided to delay OPU intentionally in women who had low percentage oocyte maturity in previous cycles.

Enrollment

20 estimated patients

Sex

Female

Ages

20 to 38 years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria: Previous 2 oocyte pick up cycles with 20% metaphase II oocytes in the cohort -

Exclusion Criteria:

No previous IVF history

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

20 participants in 1 patient group

Delay
Experimental group
Description:
Delaying oocyte pick up beyond 39 hours post hCG
Treatment:
Other: Delaying oocyte pick up beyond 39 hours post hCG

Trial contacts and locations

0

Loading...

Central trial contact

Izhar Ben Shlomo, MD; Johenny S Younis, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems